Glatiramer acetate-induced hepatitis in a patient with multiple sclerosis

被引：3
|
作者：
Flaire, A. [1 ]
Carra-Dalliere, Clarisse [1 ]
Ayrignac, X. [1 ]
Blanc, P. [2 ]
Labauge, P. [1 ]
机构：
[1] CHU Montpellier, Dept Neurol, 80 Ave Augustin Fliche, F-34295 Montpellier, France
[2] CHU Montpellier, Dept Hepatogastroenterol, F-34295 Montpellier, France
来源：
ACTA NEUROLOGICA BELGICA | 2016年 / 116卷 / 01期
关键词：
Glatiramer Acetate; Adverse Drug Reaction Probability Scale; Glatiramer Acetate Treatment; Cytolytic Hepatitis; High Dose Methylprednisolone Pulse;
D O I：
10.1007/s13760-015-0506-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [21] Optimizing glatiramer acetate-induced beneficial inflammation for myelin repair
    Yong, Wee V.
    Silva, Claudia
    Skihar, Viktor
    NEUROLOGY, 2008, 70 (11) : A29 - A29
  • [22] Glatiramer acetate (GLAT) - Induced immune activation in patients with multiple sclerosis
    Windhagen, A
    Maniak, S
    Trebst, C
    Marckmann, S
    Wilkening, A
    Lindert, RB
    Heidenreich, F
    NEUROLOGY, 2000, 54 (07) : A276 - A276
  • [23] Glatiramer acetate: Mechanisms of action in multiple sclerosis
    Ziemssen, Tjalf
    Schrempf, Wiebke
    NEUROBIOLOGY OF MULTIPLE SCLEROSIS, 2007, 79 : 537 - 570
  • [24] Is glatiramer acetate better for pregnancy in multiple sclerosis?
    Kasatkin, D. S.
    Vinogradova, T. V.
    Shitova, A. S.
    Spirin, N. N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E307 - E308
  • [25] Glatiramer acetate (Copaxone®) therapy for multiple sclerosis
    Dhib-Jalbut, S
    PHARMACOLOGY & THERAPEUTICS, 2003, 98 (02) : 245 - 255
  • [26] Evidence for use of glatiramer acetate in multiple sclerosis
    Caramanos, Z
    Arnold, DL
    LANCET NEUROLOGY, 2005, 4 (02): : 74 - 75
  • [27] Monitoring Glatiramer Acetate treatment in multiple sclerosis
    Farina, C
    Hohlfeld, R
    NEUROLOGY, 2002, 58 (07) : A246 - A246
  • [28] The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment
    Messina, Silvia
    Patti, Francesco
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (10) : 1349 - 1359
  • [29] Economic impact of glatiramer acetate in multiple sclerosis
    Ollendorf, DA
    Jilinskaia, E
    Oleen-Burkey, M
    VALUE IN HEALTH, 2002, 5 (06) : 510 - 511
  • [30] Lipoatrophy in patients with multiple sclerosis on glatiramer acetate
    Edgar, CM
    Brunet, DG
    Fenton, P
    McBride, EV
    Green, P
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2004, 31 (01) : 58 - 63
12345